Display Settings:

Format

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
    World J Gastroenterol. 2004 Feb 1;10(3):376-80.

    Hemizygous deletion and hypermethylation of RUNX3 gene in hepatocellular carcinoma.

    Source

    Department of Oncology, 304th Hospital of PLA, Beijing 100037, China. w_hxiao@hotmail.com

    Abstract

    AIM:

    To analyze the genetic and epigenetic alterations of RUNX3 gene, a potential putative tumor suppressor gene, in hepatocellular carcinoma (HCC).

    METHODS:

    PCR-based loss of heterozygosity (LOH) detection, analysis of mutation with PCR-single strand conformational polymorphism (SSCP) and sequencing, and methylation study with methylation specific PCR (MSP) were performed on RUNX3 gene in a series of 62 HCCs along with their matched normal tissues.

    RESULTS:

    Mutation of RUNX3 gene was not found, but one single nucleotide polymorphism with T to A transversion at the second nucleotide of the 18th codon was found. Nine of 26 informative cases (34.6%) showed allelic loss on the polymorphic site and 30 cases (48.4%) revealed hypermethylation of RUNX3 gene in promoter CpG islands. Furthermore, of the 9 cases with LOH, 8 (88.9%) also had hypermethylation.

    CONCLUSION:

    Our findings indicate that inactivation of RUNX3 gene through allelic loss and promoter hypermethylation might be one of the major mechanisms in hepatocellular carcinogenesis.

    PMID:
    14760761
    [PubMed - indexed for MEDLINE]
    Free full text

      Supplemental Content

      Icon for Baishideng Publishing Group Co., Limited

      Save items

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk